There was no correlation between CD5+ and nuclear expression of p52 or RelB, two subunits involved in noncanonical/alternative NF-κB pathway activation [32] (although showing trends of downregulation in CD5+ DLBCL, Figures 3F-G). Here, NFKB1 is linked to diffuse large B-cell lymphoma.